Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education.
Lisa M. Cohn, MS
Advertisement
Articles by Lisa M. Cohn, MS
Advertisement
Latest Updated Articles
- Long-Acting Beta-Agonist Monotherapy Among Children and Adults With Asthma
Published: April 14th 2011 | Updated:
- Geographic Variation of Asthma Quality Measures Within and Between Health Plans
Published: December 1st 2005 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
3
SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO
4
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
5
